Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Current Assets    
Cash $ 109.7 $ 78.4
Accounts receivable, less allowance for credit losses; $3.8 and $4.5, at September 30, 2023 and December 31, 2022, respectively 171.3 155.4
Contract assets 51.3 39.3
Inventories 54.3 67.7
Prepaid expenses 7.9 9.1
Other current assets 4.1 13.3
Total current assets 398.6 363.2
Right-of-use assets, net 49.7 44.3
Property, plant and equipment, net 48.6 42.1
Intangible assets, net 382.2 404.4
Goodwill 368.1 368.2
Deferred tax asset, net 46.6 46.6
Other assets 3.1 1.8
Total assets 1,296.9 1,270.6
Current Liabilities    
Accounts payable 56.0 52.3
Billing in excess of costs 17.9 21.4
Current maturities of long-term debt 7.1 8.3
Accrued expenses and other current liabilities 80.2 70.6
Total current liabilities 161.2 152.6
Long-term debt, net 608.5 699.9
Deferred tax liability, net 1.7 1.9
Other long-term liabilities 45.4 40.9
Total liabilities 816.8 895.3
STOCKHOLDERS’ EQUITY    
Common Stock, 825,000,000 shares authorized, $0.0001 par value, 146,828,032 and 146,703,894 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 0.0 0.0
Treasury stock, at cost, 19,833 and zero shares as of September 30, 2023 and December 31, 2022, respectively (0.2) 0.0
Additional paid-in capital 287.3 281.9
Accumulated other comprehensive loss (5.2) (4.8)
Retained earnings 198.2 98.2
Total stockholders’ equity 480.1 375.3
Total liabilities and stockholders’ equity $ 1,296.9 $ 1,270.6